Joel Haynes
24Patents
8h-index
19Co-inventors
72Inventor score
Filing activity: Jun 15, 1992 → Jun 13, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6200959A | Genetic induction of anti-viral immune response and genetic vaccine for filovirus | Chemistry; Metallurgy | 34 | Expired |
| US8841120B2 | Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity | Emerging Cross-Sectional Technologies | 24 | Active |
| US5439809A | Non-infectious HIV particles lacking long terminal repeats | Emerging Cross-Sectional Technologies | 23 | Expired |
| US9518096B2 | Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity | Emerging Cross-Sectional Technologies | 20 | Active |
| US5571712A | Non-infectious, replication defective, immunogenic HIV retrovirus-like particles produced from a recombinant HIV genome devoid of long terminal repeats | Emerging Cross-Sectional Technologies | 12 | Expired |
| US7008784B1 | Non-infectious, non-replicating, immunogenic human immunodeficiency virus-like particles | Emerging Cross-Sectional Technologies | 11 | Expired |
| US7314627B2 | Cationic lipid-mediated enhancement of nucleic acid immunization of cats | Chemistry; Metallurgy | 11 | Expired |
| US5985641A | Non-infectious, replication-impaired, immunogenic human immunodeficiency virus type 1 retrovirus-like particles with multiple genetic deficiencies | Emerging Cross-Sectional Technologies | 10 | Expired |
| US5849475A | Immunoassay diagnostic kit containing antigens derived from self-assembled, non-infectious, non-replicating, immunogenic retrovirus-like particles comprising modified HIV genomes and chimeric envelope glycoproteins | Emerging Cross-Sectional Technologies | 7 | Expired |
| US8920812B2 | Chimeric RSV-F polypeptide and lentivirus or alpha-retrovirus Gag-based VLPS | Chemistry; Metallurgy | 5 | Active |
| US9439959B2 | Chimeric influenza virus-like particles | Chemistry; Metallurgy | 3 | Active |
| US10501500B2 | Methods of detection and removal of rhabdoviruses from cell lines | Chemistry; Metallurgy | 3 | Active |
| US5912338A | Nucleic acids encoding self-assembled, non-infectious, non-replicating, immunogenic retrovirus-like particles comprising modified HIV genomes and chimeric envelope glycoproteins | Emerging Cross-Sectional Technologies | 3 | Expired |
| US7699801B2 | Advanced genetic vaccines | Emerging Cross-Sectional Technologies | 3 | Active |
| US11286282B2 | Methods of detection and removal of rhabdoviruses from cell lines | Chemistry; Metallurgy | 2 | Active |
| US5866137A | Self-assembled, non-infectious, non-replicating; immunogenic retrovirus-like particles comprising modified HIV genomes devoid of long terminal repeats and chimeric envelope glycoproteins | Emerging Cross-Sectional Technologies | 1 | Expired |
| US5972659A | Multispecific antigenic proteins | Emerging Cross-Sectional Technologies | 1 | Expired |
| US6291227A | Nucleic acids containing modified human immunodeficiency virus genomes devoid of long terminal repeats encoding non-infectious, replication-deficient, immunogenic retrovirus-like particles | Emerging Cross-Sectional Technologies | 1 | Expired |
| US7223739B1 | Adjuvanted genetic vaccines | Emerging Cross-Sectional Technologies | 1 | Expired |
| US6770282B1 | Cationic lipid-mediated enhancement of nucleic acid immunization of cats | Chemistry; Metallurgy | 1 | Expired |
| US12018052B2 | Methods of detection and removal of rhabdoviruses from cell lines | Chemistry; Metallurgy | 0 | Active |
| US12006341B2 | Methods of detection and removal of rhabdoviruses from cell lines | Chemistry; Metallurgy | 0 | Active |
| US8029776B2 | Cationic lipid-mediated enhancement of nucleic acid immunization of cats | Chemistry; Metallurgy | 0 | Active |
| US10920288B2 | Detection of particle-contained reverse transcriptase activity | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.